ASX - By Stock
|
RCE |
Re:
Ann: Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort
|
|
thirtyIV
|
7 |
2.2K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
7
|
2.2K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Shorter In The House - ASIC Where Are You?
|
|
thirtyIV
|
59 |
17K |
0 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
59
|
17K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Expansion and Acceleration of Clinical Programs
|
|
thirtyIV
|
70 |
26K |
2 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
70
|
26K
|
2
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
thirtyIV
|
2.1K |
631K |
2 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
2.1K
|
631K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
RCE price prediction 2 weeks after burns results.
|
|
thirtyIV
|
35 |
13K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
35
|
13K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
RCE price prediction 2 weeks after burns results.
|
|
thirtyIV
|
35 |
13K |
4 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
35
|
13K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
RCE Price prediction At Asx close 31st March
|
|
thirtyIV
|
43 |
12K |
2 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
43
|
12K
|
2
|
|